EGFR and colorectal carcinoma: As a critical element of the mitogen activated protein kinase (MAPK) pathway, RAS is the most common mutated gene in colorectal cancer (CRC), and its occurrence is associated with a lack of response to anti-epidermal growth factor receptor (EGFR) blockade.